(Q48152058)

9 February 2018

title

Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat. (English)

1 reference

9 February 2018

author name string

Kodama M

1

1 reference

9 February 2018

Yamada N

2

1 reference

9 February 2018

Sato K

3

1 reference

9 February 2018

Kitamura Y

4

1 reference

9 February 2018

Koyama F

5

1 reference

9 February 2018

Sato T

6

1 reference

9 February 2018

Morimoto K

7

1 reference

9 February 2018

Kuroda S

8

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

9 February 2018

European Journal of Pharmacology

published in

1 reference

9 February 2018

volume

374

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

11-19

1 reference

9 February 2018

A synaptic model of memory: long-term potentiation in the hippocampus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

NMDA but not AMPA receptor antagonists impair the delay-interposed radial maze performance of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Modification of seizure activity by electrical stimulation. II. Motor seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Pharmacokinetics and safety of the novel amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist YM90K in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

MK-801 and NBQX prevent electrically induced status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900295-2

10.1016/S0014-2999(99)00295-2

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018